Biocomm2 principals are regular participants at international conferences including Bio, BioPartnering Europe, BioEurope, BioJapan, BioAsia and AusBiotech. We are on the ground in Europe and Japan every two months to undertake and execute business development and licensing activities for clients. Biocomm2 principals have developed global network and contacts with key pharmaceutical and biotech players with wide ranges of therapeutic areas and geographical territories in order to effectively assist and deliver business success to our clients.
Our principals have completed 15 international deals in the last 5 years worth US$200million. We have been involved in more than 30 transactions over the last ten years dealing in research alliances, in-licensing, out-licensing, divestment and co-promotion.